TOTAL Trial: The Best on Manual Thrombectomy in AMI Patients

Original title: Randomized Trial of Primary PCI with or without Routine Manual Thrombectomy. Reference: S.S. Jolly et al. for the TOTAL Investigators. N Engl J Med. 2015 Apr 9;372(15):1389-98.

Manual thrombectomy is a routine procedure with ST elevation AMI patients. This common practice proved to reduce mortality in the TAPAS study. However, the TASTE study did not observe this benefit, but an increased risk of stroke. This divergent evidence inspired a comparative larger study comparing PCI vs. PCI + manual thrombectomy in STEMI patients. 

The TOTAL trial is an international, multicenter, prospective and randomized study. 10063 patients were analyzed: 5033received manual thrombectomy followed by PCI and 5030 received PCI only. Primary end point was cardiovascular death, recurrent myocardial infarction, cardiogenic shock, new cardiac failure or worsening to CF IV within 180 days. Secondary end point was in-stent thrombosis or new revascularization in addition to primary end point variables. Safety end point was stroke within 30 days.

There were no differences in primary or secondary end points (6.9% vs. 7%, p = 0.86 and 9.9% vs. 9.8%, p = 0.95, respectively).Differences were observed in safety end point, where the thrombectomy group showed a higher incidence of stroke (0.7% vs. 0.3%, p=0.02).

Conclusion

In STEMI patients, routine manual thrombectomy + PCI, compared to PCI alone, did not reduce the risk of cardiovascular death, recurrent myocardial infarction, cardiogenic shock, or NYHA class IV heart failure within 180 days. The routine manual thrombectomy strategy was associated with an increased rate of stroke within 30 days, compared to PCI alone.

Editorial Comment

Until now, the benefit of manual thrombectomy in reducing mortality with STEMI patients is not conclusive. This study, the most important work in this matter so far, shows that routine manual thrombectomy is not associated to reduced mortality, but to an increased incidence of stroke, which differs with previous studies showing this tendency. 

Two factors are worth noting: firstly, patients in the PCI group received more GP IIB/IIIA inhibitors, which may be affecting the final outcome. Secondly, the study compared routine manual thrombectomy despite thrombus load, which could also affect outcome, since manual thrombectomy in patients with low thrombus load would not benefit as much.

The present evidence does not support manual thrombectomy as a routine strategy. However, this strategy should not be discarded and should be considered for patients with post PCI high thrombus load.

Courtesy of Drs. Juan Pablo Bachini and Ariel Durán. Montevideo, Uruguay.

Dres. Juan Pablo Bachini y Ariel Durán

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...